Mitochondrial Dysfunction during the Early Stages of Excitotoxic Spinal Motor Neuron Degeneration in Vivo

Luz Diana Santa-Cruz1, Sergio Guerrero-Castillo1, Salvador Uribe-Carvajal1

  • 1División de Neurociencias and División de Investigación Básica, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México , 04510 México, D.F., México.

Insights

Mitochondrial dysfunction contributes to motor neuron death in amyotrophic lateral sclerosis (ALS). Pyruvate protects against α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) induced motor neuron damage by preventing mitochondrial impairment.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Glutamate excitotoxicity and mitochondrial dysfunction are implicated in amyotrophic lateral sclerosis (ALS) motor neuron degeneration.
  • Previous studies demonstrated that α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) perfusion causes motor neuron death via a Ca(2+)-dependent mechanism.

Purpose of the Study:

  • To investigate the role of mitochondrial dysfunction in AMPA-induced motor neuron degeneration.
  • To examine the protective effects of pyruvate on mitochondrial function during excitotoxic injury.

Main Methods:

  • Isolated mitochondria from rat spinal cords after AMPA perfusion with or without pyruvate.
  • Assessed mitochondrial function via oxygen consumption, respiratory control, and transmembrane potential measurements.
  • Analyzed respiratory chain complex activities and mitochondrial ultrastructure using electron microscopy.

Main Results:

  • AMPA perfusion led to decreased mitochondrial oxygen consumption, respiratory control, and transmembrane potential.
  • Activities of respiratory chain complexes I and IV were significantly reduced in AMPA-treated rats.
  • Electron microscopy revealed mitochondrial swelling, disorganized cristae, and membrane disruption, which were prevented by pyruvate co-perfusion.

Conclusions:

  • Mitochondrial dysfunction is a critical factor in spinal motor neuron degeneration caused by AMPA receptor overactivation in vivo.
  • These findings suggest that targeting mitochondrial dysfunction may offer therapeutic strategies for ALS.

Related Concept Videos